000 01586 a2200421 4500
005 20250514232552.0
264 0 _c20051214
008 200512s 0 0 eng d
022 _a0020-7136
024 7 _a10.1002/ijc.21279
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCastle, Philip E
245 0 0 _aHormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology.
_h[electronic resource]
260 _bInternational journal of cancer
_cDec 2005
300 _a1007-12 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650 0 4 _aContraceptive Agents, Female
_xadministration & dosage
650 0 4 _aContraceptives, Oral
_xadverse effects
650 0 4 _aDNA, Viral
_xanalysis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInjections
650 0 4 _aLevonorgestrel
_xadverse effects
650 0 4 _aLogistic Models
650 0 4 _aPapanicolaou Test
650 0 4 _aPapillomaviridae
_xgenetics
650 0 4 _aParity
650 0 4 _aPregnancy
650 0 4 _aProspective Studies
650 0 4 _aRisk Factors
650 0 4 _aVaginal Smears
650 0 4 _aUterine Cervical Dysplasia
_xepidemiology
700 1 _aWalker, Joan L
700 1 _aSchiffman, Mark
700 1 _aWheeler, Cosette M
773 0 _tInternational journal of cancer
_gvol. 117
_gno. 6
_gp. 1007-12
856 4 0 _uhttps://doi.org/10.1002/ijc.21279
_zAvailable from publisher's website
999 _c15643707
_d15643707